Adverse lower gastrointestinal effects of non-selective and COX-2 selective NSAIDs: A systematic review

被引：0
|
作者：
Laine, Loren
Smith, Rebecca A.
Min, Kejia
Chen, Connie
Dubois, Robert W.
机构：
来源：
GASTROENTEROLOGY | 2006年 / 130卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：A303 / A304
页数：2
相关论文
共 50 条
  • [21] Serious upper gastrointestinal complications of NSAIDs and COX-2 selective agents
    Sisson G.
    Bjarnason I.
    Inflammopharmacology, 2011, 19 (4) : 183 - 186
  • [22] Prevention of ulcers by esomeprazole in at-risk patients using non-selective NSAIDs and COX-2 inhibitors
    Scheiman, JM
    Yeomans, ND
    Talley, NJ
    Vakil, N
    Chan, FKL
    Tulassay, Z
    Ralnoldi, JL
    Szczepanski, L
    Ung, JA
    Kleczkowski, D
    Ahlbom, H
    Næsdal, J
    Hawkey, C
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2006, 101 (04): : 701 - 710
  • [23] Co-prescription of gastroprotective agents in patients taking non-selective NSAIDs or COX-2 selective inhibitors analysis of prescriptions
    Pasina, L.
    Nobili, A.
    Tettamanti, M.
    Riva, E.
    Lucca, U.
    Picinelli, R.
    Defendi, L.
    Perego, L.
    Lucifora, S.
    Bulla, C.
    INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS, 2010, 48 (11) : 735 - 743
  • [24] All-cause mortality of elderly Australian veterans using COX-2 selective or non-selective NSAIDs: a longitudinal study
    Kerr, Stephen J.
    Rowett, Debra S.
    Sayer, Geoffrey P.
    Whicker, Susan D.
    Saltman, Deborah C.
    Mant, Andrea
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2011, 71 (06) : 936 - 942
  • [25] Esomeprazole relieves NSAID-associated upper GI symptoms in patients taking either continuous cox-2 selective nsaids or non-selective nsaids
    Kean, W
    JOURNAL OF RHEUMATOLOGY, 2005, 32 (07) : 1389 - 1389
  • [26] Effects of a non-selective COX inhibitor and selective COX-2 inhibitors on contractility of human and porcine ureters in vitro and in vivo
    Chaignat, V.
    Danuser, H.
    Stoffel, M. H.
    z'Brun, S.
    Studer, U. E.
    Mevissen, M.
    BRITISH JOURNAL OF PHARMACOLOGY, 2008, 154 (06) : 1297 - 1307
  • [27] NSAIDs: gastroprotection or selective COX-2 inhibitors?
    Davis, MP
    PALLIATIVE MEDICINE, 2005, 19 (02) : 165 - 165
  • [28] NSAIDs: gastroprotection or selective COX-2 inhibitor?
    Dickman, A
    Ellershaw, J
    PALLIATIVE MEDICINE, 2004, 18 (04) : 275 - 286
  • [29] Risks and benefits of COX-2 inhibitors vs non-selective NSAIDs:: does their cardiovascular risk exceed their gastrointestinal benefit?: A retrospective cohort study
    Rahme, E.
    Nedjar, H.
    RHEUMATOLOGY, 2007, 46 (03) : 435 - 438
  • [30] COX-2-selective NSAIDs: adverse effects reduced, but not eliminated
    Reactions Weekly, 2000, 820 (1) : 3 - 3
12345